Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

Attorneys say the FDA is unlikely to challenge the court’s decision, though Congress could still look to modernize lab test ...

CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare ...

CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.

Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

The median deal size for late-stage funding rounds was $105 million, nearly double the $55 million check size across 2024.

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

GE Healthcare and Medtronic said they are preparing mitigation plans as they assess the potential ramifications of Trump’s ...

Amid the whirlwind of tariff news, AdvaMed and other healthcare groups have pleaded for the Trump administration to exempt ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

The restructuring plan comes about six weeks after Teleflex announced it would split into two separate, public entities.